<- Go Home
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
Market Cap
$65.3M
Volume
637.8K
Cash and Equivalents
$28.3M
EBITDA
-$98.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$72.8M
Profit Margin
-1040.71%
52 Week High
$1.14
52 Week Low
$0.52
Dividend
N/A
Price / Book Value
0.43
Price / Earnings
-0.66
Price / Tangible Book Value
0.43
Enterprise Value
-$81.3M
Enterprise Value / EBITDA
0.87
Operating Income
-$99.5M
Return on Equity
-51.48%
Return on Assets
-28.07
Cash and Short Term Investments
$164.2M
Debt
$17.6M
Equity
$150.7M
Revenue
$7.0M
Unlevered FCF
-$40.7M
Sector
Biotechnology
Category
N/A